Cindy Chang

Cindy Chang is a senior associate at Gemini. She has extensive experience with all aspects of intellectual property issues in various industries, both as a litigation associate at large law firms as well as in-house IP counsel at a large pharmaceutical company. She has been trained in biology and medicine and brings a deep technical understanding to legal issues in the biopharma space.

As in-house counsel at a pharmaceutical company, Cindy provided legal counsel on various patent-related issues, including providing freedom to operate and design-around analyses to support product selection and pipeline management, drafting IP provisions in commercial agreements, identifying patentable subject matter, patent prosecution, and advising on Hatch-Waxman and BPCIA litigation. She also provided counsel on regulatory issues relating to ANDA submissions.

As a litigation associate at large law firms, Cindy represented both plaintiffs and defendants in diverse intellectual property matters, including patent, trademark, and trade secret cases. She has deep experience in all stages of civil litigation, having managed cases from pre-suit investigation through trial (including two bench trials, two jury trials, and one arbitration). She also has experience with PTAB proceedings, and was the primary drafter of a petition for inter partes review on an antibody patent; IPR was instituted. She maintained an active pro bono practice, and won two appeals for social security benefits, and drafted amicus briefs on immigration and criminal justice matters.

Prior to practicing law, Cindy studied cancer biology while pursuing a dual-degree MD/PhD program, researching the mechanisms underlying Yap1-driven development of hepatocellular carcinoma.